U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949891) titled 'KETOgenic Diet Therapy in Patients With ACROmegaly' on March 06.
Brief Summary: Acromegaly is caused by a tumour located at the base of the brain in the pituitary gland that produces too much growth hormone (GH). Symptoms caused by the excess of GH, and consequently increased insulin like growth factor 1 (IGF-1), are disproportionate growth of body parts, fluid retention, snoring and excessive perspiration. The various metabolic changes that occur due to acromegaly increase the risk for insulin resistance, diabetes mellitus, arterial hypertension, sleep apnoea and thus an increased risk of cardiovascular disease if left untreated. ...